Moleculin Biotech, Inc. (MBRX) Operating cash flow 2016–2025
Moleculin Biotech, Inc. (MBRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.7MFY2025 · since FY2016: -$3.8M → -$22.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.7M | +4.7% |
| FY2024 | -$23.9M | -1.1% |
| FY2023 | -$23.6M | +14.6% |
| FY2022 | -$27.6M | -45.8% |
| FY2021 | -$19.0M | -6.6% |
| FY2020 | -$17.8M | -3.3% |
| FY2019 | -$17.2M | -40.9% |
| FY2018 | -$12.2M | -66.6% |
| FY2017 | -$7.3M | -94.5% |
| FY2016 | -$3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice